Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 353

Fear and greed in markets: where to from here?

The past few weeks have been a time of unprecedented turmoil and volatility in global equity markets. Closer to home, the Australian equity market had its fastest 30% fall in the history of the Australian Securities Exchange, with only the 1987 crash coming close in terms of severity. It took a week longer during the 1987 crash to reach the 20% drawdown mark.

However, what has also taken the market by surprise has been the speed of recovery in prices. Since bottoming in late March, many companies have more than doubled in price in just two weeks, ahead of potential earnings downgrades.

Extreme volatility such as this is a sure sign of investor uncertainty and lack of conviction. Equity markets have always been forward-looking, with movement merely reflecting changes in future expected earnings of the companies, magnified by sentiment such as fear and greed.

Where are we now?

To assess where we are in the current equity market cycle, it is important to take stock of some of the economic realities.

Investors’ fears are well-warranted. Western economies have responded to the spread of COVID-19 by shutting down social events, venues and other gatherings, which has seen a vast number of casual staff being laid off. For most OECD countries, over 60% of their GDP lies in consumer spending, and a consumption-led recession will inevitably lead to a material rise in unemployment over the next three to six months.

On a positive note, because equity markets are forward-looking, if authorities are able to control the COVID-19 outbreak quickly, it would see many companies’ earnings bounce back reasonably quickly, particularly with the significant pending stimulus. Trillions of dollars around the world has been deployed to stimulate economies, much of that yet to be spent. Central banks have learned that during times of stress, keeping money flowing in the economy is paramount.

Based on the action plan announced by the Reserve Bank of Australia, the Federal Government and other regulatory bodies, we believe the stimulus plan is sufficient for the current environment. One key variable at this stage is how long we will be in lock-down before consumers can be allowed out to spend the stimulus provided.

Australia has continued to manage the outbreak of COVID-19 much better than most other countries. We attribute this to the early and decisive actions taken by State and Federal Governments to close borders and introduce mitigation strategies to slow the rate of contagion. This, along with world-leading COVID-19 testing, has ensured the epidemic has had a manageable impact on the hospital system.

The focus of investors and the broader population is now turning to when these measures can be relaxed given the extraordinary impact on the economy and Government finances. We expect the Government to take a cautious approach such that the current social distancing and work from home policies will likely, to a large extent, remain in place for some weeks, if not months, yet. However we are hopeful things will start to normalise by the start of the new financial year.

Portfolio positioning

As an active manager, we see current market conditions as ripe for opportunity to add to high quality portfolio stocks, while maintaining an overweight in quality defensive sectors such as healthcare. Stock specifically, the top 10 holdings in the Tribeca Alpha Plus fund have delivered exceptional returns since the crisis hit.

Fisher and Paykel has upgraded earnings twice, largely as a result of the surge in demand for its hospital respiratory products (which account for more than 60% of group revenue).

A2 milk has surprised the market with its resilience across its distribution platforms. Mothers in China flocked online to stock up on quality-branded infant formula and as a strong online player, A2 has been well placed to benefit. This will likely cement its brand in the offline Chinese consumer segment too.

Coles Group is another top holding which has seen significant improvement in its sales as consumers are moving to stock up their pantries. It has also meaningfully outperformed its peers, including Woolworths, which we don’t hold in our portfolio.

More recently, we have increased our holdings in a number of other high quality businesses, including AfterPay and Tyro, both of which have short-term earnings sensitivity to economic conditions.

Our investment thesis for such growth businesses has always been premised upon their future growth opportunity, and the strength and longevity of their respective business models. One quarter of weak earnings does not change our view, although we are regularly testing our assumptions based on current economic conditions and duration of the COVID-19 lockdown. We have little doubt that once the market stabilises, these two businesses will meaningfully outperform. Indeed, at the time this article is written, both stocks have more than doubled since lows reached at the end of March.


Jun Bei Liu is Portfolio Manager at Tribeca Investment Partners. The information in this article is provided for informational purposes only. Any opinions expressed in this material reflect our judgment at this date and should not be relied upon as the basis of your investment decisions.


April 30, 2020

I think its safe to say this virus will be present in most countries until a vaccine is found or perhaps something to take the edge off its severity. Either which way , as clever as we humans can be you don't just serve up a vaccine shot to seven billion people in a couple of weeks. Delivery will take months. In the meantime the world economy will spiral down. Usually I like to think of something positive to cap off something negative. Perhaps in time to come there will be a lot more humble people in the world. That can't be a bad thing?

April 23, 2020

The movement of the market swings and the magnitude on a daily basis are unpredictable which proves to me that nobody I repeat nobody has the faintest idea what will happen next and how long before the markets return to somewhere near normal. The so called experts agree on one thing , they disagree, if you get the drift. I have been in the market since 1963 and I disagree with myself. I believe if you think you can pick what is going to happen next at this moment, you're a fool or a liar, I mean that in a friendly way. The best of luck to you all.

Reader comment
April 19, 2020

Oh! For a crystal ball. They say if the US sneezes, the rest of the World gets a cold. The US has a lot more pain to go from both a health and financial perspective. Sharemarkets are predictive so tend to be ahead of the game except for black swan events. The bottom will occur shortly before the easing of social and business restrictions in the US. Trump is a maverick, risk taker and it is an election year so there is a real danger that easing will occur too early and a second wave results in the US.

April 17, 2020

"One quarter of weak earnings does not change our view". Is that your "view"? There will be only one quarter of weak earnings? I would suggest there will be at least two quarters where earnings for many companies will be decimated or even non existent for a small minority and as to a normalising of conditions thereafter who really knows the rapidity or the extent of a recovery? Risk is being underestimated yet once again.
Analysts are widely using historical earnings estimates while many companies have explicitly withdrawn earnings guidance because they have no idea what they will be. I suspect that revisions to earnings will be large going forward.

April 16, 2020

Down, down, down ... up, up ... down, down ... as if we know where it's going next. Glad I'm not investing for people who rely on me.


Leave a Comment:



Chris Cuffe on why private debt is a hidden gem

COVID-19: Is this time really different?

Coronavirus and a roadmap for infected investing


Most viewed in recent weeks

Easy money: download Robinhood, buy stonks, bro down

Millions of inexperienced traders have entered global equity markets since the end of March, fuelled by hype in a rapidly-rising market. What is happening and how are they having an impact?

Warren Buffett's letter about new investors and speculation

A pin lies in wait for every bubble. And when the two eventually meet, a new wave of investors learns some very old lessons: speculation is most dangerous when it looks easiest.

10 reasons to sell your dud stocks for EOFY

Anyone with capital gains from property or shares should take this EOFY opportunity to find offsetting capital losses. There are many benefits from cleaning out the portfolio stuff-ups.

How much bigger can the virus bubble get?

Stocks have rallied hard creating a virus bubble, but will this run for years or collapse in a matter of months? The market is giving a second chance to leave so head for the exit before there's a rush.

Share trading is the new addiction

The ability to buy and sell cheaply and quickly in small parcels is both the biggest drawback and benefit of shares. But it encourages people who should not go near the market to use it as a casino.

The populations of key countries are shrinking

Population decline is a new, yet largely ignored, trend with underrated economic and social costs. Much of the growth that drives economies, especially in Australia, comes from population increases.

Latest Updates

Howard Marks' anatomy of an unexpected rally

Markets can swing quickly from optimism to pessimism, and while there are more positives now than in the bleak early days in March, the market is ignoring many negatives. Risk is not rewarded at these levels.  

Why are we convinced 'this time it's different'?

Investors tend to overstate the impact on investments when something significant happens and they assume the future will be different. COVID-19 has been dramatic, but is it really that unusual?   


Super fund performance and rank depends on risk

APRA's heatmap has profound implications as it shows which super funds are underperforming in a period. But when good markets are compared with poor markets, one in five of funds changes its assessment.    

Investment strategies

Why women are most hurt by financial pandemic

Many people were financially unprepared for a pandemic, but it is women who are suffering most because they earn less, have interrupted careers and have less risk-taking capacity.


What is happening with SMSFs? Part 2

The latest SMSF data shows retirees favour listed shares and cash to maintain liquidity. SMSFs continue to grow, and the new super rules led to changes in contributions, payments and lump sums.


Retirement dreams face virus setback

A new survey of over 1,000 people near or in retirement found three in four are not confident how long their money will last. Only 18% felt their money was safe during a strong economic downturn.


Common confusions with death benefit pensions

Awareness of common misunderstandings in relation to the payment of death benefit pensions can assist in estate planning matters. Given the large amounts involved, seeking professional advice helps.



© 2020 Morningstar, Inc. All rights reserved.

The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use.
Any general advice or class service prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, has been prepared by without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.